Question:
Blockade in ẞ-oxidation results in :
Blockade in ẞ-oxidation results in :
Updated On: Jul 16, 2024
- Von Gierk's disease
- Scurvy
- Sudden infant death syndrome
- Taruli's disease
Hide Solution
Verified By Collegedunia
The Correct Option is C
Solution and Explanation
The correct option is (C) : Sudden infant death syndrome
Was this answer helpful?
0
0
Top Questions on Biological oxidations & reductions
- How many molecules of acyl-CoA are produced in beta-oxidation of palmitic acid
- GPAT - 2021
- Biochemistry
- Biological oxidations & reductions
- Which of the following is a characteristic of cytochrome P-450
- GPAT - 2017
- Biochemistry
- Biological oxidations & reductions
- Proton pump inhibitors are most effective when given
- GPAT - 2014
- Biochemistry
- Biological oxidations & reductions
- Match compounds is Group I with inhibitory activities in Group II
Group I Group II (P) Vancomycin (1) Folate metabolism (Q) Rifampin (2) DNA synthesis (R) Puromycin (3) Protein synthesis (S) Ciprofloxacin (4) RNA synthesis (5) Cell wall systhesis - GPAT - 2014
- Biochemistry
- Biological oxidations & reductions
- Increase in melting temperature of DNA is due to high content of
- GPAT - 2014
- Biochemistry
- Biological oxidations & reductions
View More Questions
Questions Asked in GPAT exam
- Which of the following alkaloids are found as salts of meconic acid?
- GPAT - 2025
- Introductory Pharmacognosy
Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing
- GPAT - 2025
- Drug therapy
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
- Which of the following nasal decongestants is an \(\alpha_2\) agonist?
- GPAT - 2025
- Biostatistics and Research Methodology
View More Questions